if penn experiment goes well , larger clinical trials would follow . but " well " is subjective . measures such as whether a patient is alive or dead are , of course , tough to fudge . how bad side effects are , less so . judgment calls can even enter into assessments of how significantly and for how long tumors have shrunk .